Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ironwood Pharmaceuticals (IRWD) Treasury Shares: 2010-2024

Historic Treasury Shares for Ironwood Pharmaceuticals (IRWD) over the last 14 years, with Dec 2024 value amounting to $5.4 million.

  • Ironwood Pharmaceuticals' Treasury Shares rose 0.16% to $5.4 million in Q4 2024 from the same period last year, while for Dec 2024 it was $5.4 million, marking a year-over-year increase of 0.16%. This contributed to the annual value of $5.4 million for FY2024, which is 0.16% up from last year.
  • Per Ironwood Pharmaceuticals' latest filing, its Treasury Shares stood at $5.4 million for FY2024, which was up 0.16% from $5.3 million recorded in FY2023.
  • In the past 5 years, Ironwood Pharmaceuticals' Treasury Shares registered a high of $5.4 million during FY2024, and its lowest value of $3.9 million during FY2021.
  • In the last 3 years, Ironwood Pharmaceuticals' Treasury Shares had a median value of $5.3 million in 2023 and averaged $5.0 million.
  • Per our database at Business Quant, Ironwood Pharmaceuticals' Treasury Shares surged by 30.04% in 2020 and then fell by 7.35% in 2021.
  • Ironwood Pharmaceuticals' Treasury Shares (Yearly) stood at $4.2 million in 2020, then dropped by 7.35% to $3.9 million in 2021, then rose by 11.03% to $4.3 million in 2022, then increased by 24.53% to $5.3 million in 2023, then climbed by 0.16% to $5.4 million in 2024.